Trial
NCT00964288
Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Biogen
Collaborators
—
Condition
Pain, Neuropathic
Intervention
GSK1014802 low dose
Why stopped
During treatment session 3, a subject had a pattern of AEs of severe intensity, suggestive of brainstem toxicity/encephalopathy during lidocaine/saline infusion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-26